Emcure Pharmaceuticals To Launch Oral COVID-19 Drug In A Week�s Time In India

[email protected]10 Jan, 2022News

Emcure Pharmaceuticals announced that it has received an Emergency Use Authorisation (EUA) approval from the Drug Controller General of India (DCGI) for launching Molnupiravir to treat mild COVID-19. The company plans to launch the oral drug under the brand name Lizuvira in the Indian market, the company said in a statement. As the need for such a drug is imminent in the face of emerging challenges in COVID- 19 treatment, the company will endeavour to deliver Lizuvira in a week?s time. A toll-free helpline will be dedicated to help the doctors and patients access the product.